Tina Lin

Tina Lin

MBBS; FRACP (Cardiology); EHRA Fellowship; Clinical Electrophysiology Fellowship

Cardiologist

21+ years of Experience

Female📍 Heidelberg

About of Tina Lin

Tina Lin is a Cardiologist based in Burgundy Street, Heidelberg, VIC 3084. She also works as an electrophysiologist, so a lot of her day-to-day care focuses on rhythm problems, not just general heart health.

Over time, Tina has built a steady practice looking after people with heart rhythm conditions and related symptoms. This can include atrial fibrillation, fast or irregular heartbeats, ectopic beats, and issues like sick sinus syndrome. At times, patients also come in with problems such as paroxysmal supraventricular tachycardia (PSVT), ventricular tachycardia, or other arrhythmias. She also sees people after heart attacks and helps manage heart failure when rhythm and heart function are both part of the story.


Tina works with patients who have had strokes or transient ischaemic attacks (TIA), especially when blood flow and heart rhythm raise questions about risk. She also cares for people who need advanced treatment for rhythm disorders, including cardiac ablation. In some cases, the work may extend to managing more urgent complications that can affect the heart, such as cardiac tamponade or dangerous irregular rhythms like ventricular fibrillation.


In many cases, the goal is simple: help people feel safer and more in control. That can mean checking what’s causing the symptoms, mapping the electrical signals, and then deciding on the best next step. For some patients, that may involve procedures such as ablation. For others, it may be about medication planning and long-term follow-up.


Tina has more than 21 years of experience. Her clinical background includes working as a cardiology registrar at Austin Health and Monash Medical Centre, with training earlier through basic physician years at Austin Health. She later completed advanced training and fellowships in cardiac pacing and electrophysiology, including time with the European Heart Rhythm Association and a clinical electrophysiology fellowship in Hamburg, Germany.


Her qualifications include MBBS from the University of Melbourne, FRACP (Cardiology), an EHRA Fellowship in Electrophysiology, and a Clinical Electrophysiology Fellowship.


When it comes to evidence and learning, Tina has published research in medical journals. She also keeps up with new approaches through ongoing professional work, so care stays current and grounded in what helps patients in real life.

OPD Timing

Warringal Private Hospital

Suite 1, 216 Burgundy Street, Heidelberg VIC 3084

Monday8:30am - 5:00pm
Tuesday8:30am - 5:00pm
Wednesday8:30am - 5:00pm
Thursday8:30am - 5:00pm
Friday8:30am - 5:00pm
Saturday
Sunday

Education

  • MBBS; University of Melbourne; 2004
  • FRACP (Cardiology); Royal Australasian College of Physicians; 2012
  • EHRA Fellowship (Electrophysiology); European Heart Rhythm Association; 2012
  • Clinical Electrophysiology Fellowship; Asklepios Klinik St. Georg, Hamburg, Germany; 2014

Services & Conditions Treated

Atrial FibrillationCardiac AblationCardiac TamponadeVentricular FibrillationArrhythmiasEctopic HeartbeatHeart AttackHeart FailureParoxysmal Supraventricular Tachycardia (PSVT)Pulmonary Vein StenosisSick Sinus SyndromeStrokeTransient Ischemic Attack (TIA)Ventricular Tachycardia

Publications

5 total
Effect of Feminizing Hormone Therapy on QTc Interval: A Secondary Analysis of a Randomized Clinical Trial.

JAMA network open • March 28, 2024

Lachlan Angus, Tina Lin, Shalem Leemaqz, Ada Cheung

The adult QT interval has sex-specific reference ranges, reflecting a decrease in the QT interval by 20 ms after male puberty.1 The QT interval appears to be modulated by serum testosterone concentrations; it is prolonged in men treated with androgen deprivation therapy for prostate cancer2 and shortened in women with hyperandrogenism.3 A 2022 cohort study4 showed an increased risk of arrhythmia in transgender women compared with cisgender women, but the mechanisms are unclear. We examined the effect of feminizing hormone therapy on the QT interval in transgender women and nonbinary or transfeminine individuals and hypothesized that this would be prolonged due to suppression of serum testosterone levels.

Late recurrence of atrial fibrillation and flutter in patients referred for elective electrical cardioversion.

Kardiologiia • April 19, 2022

Liam Toner, Helena Proimos, Timothy Scully, Jefferson Ko, Anoop Koshy, Mark Horrigan, Han Lim, Tina Lin, Omar Farouque

Aim The primary aim was to ascertain long-term rates of atrial fibrillation (AF) recurrence in this all-comer patient population undergoing elective electrical cardioversion (DCR). Secondary aims included procedural DCR success, clinical predictors of long-term maintenance of sinus rhythm (SR) and AF related hospitalizations.Material and Methods A retrospective cohort study was conducted. Consecutive patients (n=316) undergoing elective DCR were included.Results Successful immediate reversion to SR was attained in 266 (84 %) of patients. 224 (84 %) patients were followed up for a median period of 3.5 years (IQR 2.7-4.3). Most patients (150 [67 %]) had recurrence of AF / flutter at a median time of 240 days. Clinical predictors of AF recurrence included a history of AF (HR 0.63, p=0.038) and a dilated left atrium (HR 4.13, p=0.048). Maintenance of SR was associated with fewer unplanned hospitalizations for AF (HR 3.25, p<0.01).Conclusion There was high procedural success post DCR. However, long-term rates of AF recurrence were high, and AF recurrences were associated with increased hospitalizations. These findings underscore the importance of clinical vigilance and multi-modal management as part of a comprehensive and effective rhythm control strategy.

Clinical Impact of Circulating Galectin-3 on Ventricular Arrhythmias and Heart Failure Hospitalization Independent of Prior Ventricular Arrhythmic Events in Patients with Implantable Cardioverter-defibrillators.

Internal Medicine (Tokyo, Japan) • April 04, 2022

Hisaki Makimoto, Patrick MĂĽller, Kullmann Denise, Lukas Clasen, Tina Lin, Stephan Angendohr, Jan Schmidt, Christoph Brinkmeyer, Malte Kelm, Alexandru Bejinariu

Objective For risk stratification of sudden cardiac death in patients with structural heart disease, more precise predictors in addition to left ventricular ejection fraction (LVEF) are clinically needed. The present study assessed the utility of galectin-3 as an independent indicator for the prognosis of heart failure patients with implantable cardioverter-defibrillators (ICD). Methods The study population consisted of 91 consecutive patients who underwent a routine ICD checkup in our ICD outpatient clinic. Circulating galectin-3 was assessed using a commercially available enzyme-linked immunosorbent assay kit. The enrolled patients were prospectively followed. The primary endpoint was defined as the occurrence of appropriate ICD therapy (AIT), and the secondary endpoint was defined as the occurrence of unplanned overnight hospitalization due to decompensated heart failure (dHF). Results During a mean follow-up of 472±107 days, AIT occurred in 18 patients (20%). Unplanned hospitalizations due to dHF were noted in 12 patients (13%). A receiver-operative characteristics analysis demonstrated a sensitivity of 83% and specificity of 68% for AIT occurrences with a galectin-3 cut-off value of 13.1 ng/mL (area under the curve =0.82). A Kaplan-Meier analysis demonstrated that patients with galectin-3 >13.1 ng/mL had significantly higher incidences of AIT as compared to those with lower galectin-3 (log-rank, p<0.001). This significance was also observed in both subgroup analyses with ischemic and non-ischemic etiology. Cox regression demonstrated that higher galectin-3 was an independent predictor of AIT and dHF, even after adjusting for previous arrhythmic events. Conclusion The circulating galectin-3 level can be used as a clinical indicator of subsequent occurrence of ventricular arrhythmic events and decompensated heart failure, regardless of a history of ventricular arrhythmias.

Atrial Tachyarrhythmias and Stroke: Temporal Relationship and Stroke Subtypes.

Cerebrovascular Diseases (Basel, Switzerland) • February 08, 2022

Hugh Blackie, Vincent Thijs, Leonid Churilov, Hui-chen Han, Tina Lin, Andrew Teh, Elizabeth Jones, Mark Horrigan, Omar Farouque, Han Lim

Background and purpose: Research into the temporal relationship between atrial tachyarrhythmias (atrial tachycardia [AT] and atrial fibrillation [AF]) and stroke has produced conflicting findings. Systematic categorization of stroke subtypes may help clarify the discussion. Objectives: The objective of the study was to examine the presence and timing of AT/AF in relation to ischemic stroke subtypes, categorized as either cardioembolic (CE) or non-CE. Methods: Consecutive patients presenting to the Austin Hospital with acute stroke from 2012 to 2019 and a cardiac implantable electronic device (CIED) were identified. Using a case-control design, the temporal proximity of AT/AF episodes in the 90 days prior to stroke was compared in the CE and non-CE stroke groups. Results: 5,591 patients presented to the Austin Hospital with acute stroke from 2012 to 2019, of whom 31 patients with an ischemic stroke and a CIED with ≥90 days of monitoring were identified. Twelve strokes were adjudicated as CE and 19 as non-CE by a stroke neurologist. Six of the 12 CE stroke patients (50%) experienced AT/AF within 30 days preceding their stroke, while none of the 19 non-CE stroke patients recorded any AT/AF in the same period (p = 0.001). Four CE stroke patients (33%) had no AT/AF preceding their strokes at any time. The odds ratio for CE stroke was highest (39; 95% confidence interval [CI]: 1.92-791.5) when AT/AF occurred in the 30 days prior, declining to 20.65 (95% CI: 1.00-427.66) and 6.07 (95% CI: 0.94-39.04) in the subsequent 31-60- and 61-90-day windows, respectively. Conclusions: CE strokes were associated with a significantly higher proportion of preceding AT/AF compared with non-CE strokes. These findings support a potential temporal relationship between AT/AF and CE stroke and demonstrate that stroke subtyping can better characterize the relationship between AF and ischemic stroke. However, this study's findings are limited by its sample size and small number of informative cases.

High anatomical accuracy of a novel high-resolution wide-band dielectric imaging system in cryoballoon-based ablation.

Pacing And Clinical Electrophysiology : PACE

Laura Rottner, Milena Nodorp, Weimann Jessica, Ruben Schleberger, Christoph Sinning, Marc Lemoine, Leon Dinshaw, Paula MĂĽnkler, Tina Lin, Christian Meyer, Bruno Reissmann, Andreas Metzner, Andreas Rillig

Objective: Recently, a novel cardiac imaging system based on a wide-band dielectric technology (KODEX-EPD) was introduced to guide catheter ablation. The aim of the study was to evaluate this 3D wide-band dielectric imaging system (WDIS) during cryoballoon (CB)-based atrial fibrillation (AF) ablation focusing on accuracy of pulmonary vein (PV)-anatomy. Methods: In consecutive patients with symptomatic AF, CB-based ablation was performed in conjunction with the 3D WDIS. Selective PV-angiographies were performed, and 3D anatomy of the left atrium (LA) and PVs using the 3D WDIS was created. The ostial diameters of the ipsilateral right-sided and left-sided PVs and ostial diameters of the right-/left-sided upper/lower PVs demonstrated by selective angiographies were analyzed and compared to 3D WDIS-based PV visualization. Results: In 65 patients (42/65 (65%) male, age 65 ± 9 years, 29/65 (45%) paroxysmal AF) a total of 260 PVs were identified. Median ostial PV-diameters for the ipsilateral left- and right-sided PVs were 38 [34; 43] and 37 [34; 40.3] mm when assessed fluoroscopically and 40 [35.7; 43] and 39 [35.0; 43] mm as demonstrated by 3D WDIS. There was no statistically significant difference between both methods regarding PV-diameter measurements. KODEX-EPD overestimated fluoroscopy measurements by 1.08 mm (95% limits of agreement of -1.93 mm and 4.1 mm). Conclusions: The novel wide-band dielectric 3D-imaging system is feasible to create high-resolution images of cardiac structures during CB ablation procedures and accurately visualizes PV-anatomy.

Frequently Asked Questions

What services does Dr Tina Lin provide?
Dr Tina Lin offers care for heart rhythm and related conditions, including atrial fibrillation, arrhythmias, PSVT, ventricular tachycardia, sick sinus syndrome, and treatments like cardiac ablation. She also manages heart failure, heart attack care, stroke and TIA, and issues such as pulmonary vein stenosis and cardiac tamponade.
Which conditions does Dr Lin treat?
Her focus covers common and complex heart rhythm problems and related conditions, such as atrial fibrillation, ventricular arrhythmias, sick sinus syndrome and PSVT, plus the risks and consequences of heart attack, stroke and heart failure.
Where is Dr Lin’s clinic located?
Her practice is in Heidelberg, at Burgundy Street, Heidelberg, VIC 3084, Australia.
What should I expect at a cardiology appointment with Dr Lin?
You’ll have a discussion about your heart symptoms, review test results if available, and discuss treatment options for rhythm problems or related heart conditions. She uses evidence-based care for conditions like atrial fibrillation and arrhythmias.
Does Dr Lin perform procedures?
Yes. She offers procedures related to heart rhythm, including cardiac ablation for arrhythmias.
What qualifications does Dr Lin have?
Dr Lin has an MBBS and FRACP in Cardiology, plus EHRA Fellowship and a Clinical Electrophysiology Fellowship, with over 21 years of experience.

Contact Information

Burgundy Street, Heidelberg, VIC 3084, Australia

Is this your profile?

Claim this profile →

Memberships

  • Fellow of the Royal Australasian College of Physicians (FRACP)
  • Cardiac Society of Australia and New Zealand (CSANZ)
  • European Heart Rhythm Association (EHRA)